Patents by Inventor Rajesh Gontla

Rajesh Gontla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kinase inhibitors and their use in cancer therapy
    Patent number: 10550114
    Abstract: The present invention relates to a 2,3-diphenyl-1,6-naphthyridine-5-one derivative according to general formula (I), and the use of the 2,3-diphenyl-1,6-naphthyridine-5-one derivative in the diagnosis or treatment of cancer.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: February 4, 2020
    Assignee: TECHNISCHE UNIVERSITÄT DORTMUND
    Inventors: Daniel Rauh, Rajesh Gontla, Jörn Weisner
  • KINASE INHIBITORS AND THEIR USE IN CANCER THERAPY
    Publication number: 20180354941
    Abstract: The present invention relates to a 2,3-diphenyl-1,6-naphthyridine-5-one derivative according to general formula (I), and the use of the 2,3-diphenyl-1,6-naphthyridine-5-one derivative in the diagnosis or treatment of cancer.
    Type: Application
    Filed: May 3, 2016
    Publication date: December 13, 2018
    Applicant: TECHNISCHE UNIVERSITÄT DORTMUND
    Inventors: Daniel Rauh, Rajesh Gontla, Jörn Weisner